Affordable Access

[Cell replacement therapy for Parkinson's disease using iPS cells].

Authors
Type
Published Article
Journal
Rinshō shinkeigaku = Clinical neurology
Publication Date
Volume
53
Issue
11
Pages
1009–1012
Identifiers
PMID: 24291862
Source
Medline

Abstract

The aim of stem cell therapy for Parkinson's disease (PD) is to reconstruct local synapse formation and/or induce the release of dopamine and cytokines from grafted cells in the putamen. Fetal ventral-midbrain cells are reported to relieve the neurological symptoms of PD patients. However, not only embryonic stem cells (ESCs), but also induced pluripotent stem cells (iPSCs) are expected to provide an alternative donor cell population because of their capacity for self-renewal and pluripotency. A protocol to generate dopaminergic (DA) neurons from ESCs and iPSCs has been developed, and human ESCs were proven to function in the brain of rat and monkey PD models. The next step will be the isolation of DA neurons as a donor cell population for a safe and efficient transplantation.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F